During the past decade, SHOGAT Prof Dimitar Stamatov conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "SHOGAT Prof Dimitar Stamatov" #1 collaborator was "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "SHOGAT Prof Dimitar Stamatov" are "Endometriosis" (1 trials), "Hot Flashes" (1 trials), "Retinopathy of Prematurity (ROP)" (1 trials), "Uterine Fibroids" (1 trials) and "Vasomotor Symptoms Associated With Menopause" (1 trials). Many other conditions were trialed in "SHOGAT Prof Dimitar Stamatov" in a lesser frequency.

Most popular intervention types in "SHOGAT Prof Dimitar Stamatov" are "Drug" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "BAY1817080" (1 trials), "Elagolix" (1 trials), "Elinzanetant (BAY3427080)" (1 trials) and "Eylea (Aflibercept, BAY86-5321)" (1 trials). Other intervention names were less common.

The vast majority of trials in "SHOGAT Prof Dimitar Stamatov" are 3 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "SHOGAT Prof Dimitar Stamatov". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in SHOGAT Prof Dimitar Stamatov, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SHOGAT Prof Dimitar Stamatov, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".